86 Participants Needed

Robotic-Assisted Knee Replacement for Osteoarthritis

JL
Overseen ByJacqueline Lenahan, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a robot can improve outcomes in knee replacement surgery for individuals with severe knee arthritis. The study compares robotic-assisted surgery, specifically using the Navio™ Robotics-assisted Surgical System, with conventional methods to determine which reduces pain and improves knee function more effectively. Individuals with long-standing severe knee arthritis who have not found relief with other treatments might be suitable candidates. Participants will receive the same implants and care, but the surgical technique will differ between groups. As an unphased trial, this study allows participants to contribute to innovative research that could enhance future surgical techniques.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the Navio™ Robotics-assisted Surgical System is safe for knee replacement surgery?

Research has shown that the Navio™ Robotics-assisted Surgical System is generally safe for knee surgeries. Studies have found that this system accurately aligns the knee in over 93% of cases, indicating its effectiveness. However, like any medical procedure, complications can occur. Reported issues include small fractures near pin placements, infections, soft tissue injuries, and more blood loss than expected. Although these problems are uncommon, they are important to consider. Overall, the system is well-tolerated, but awareness of these possible side effects is advisable.12345

Why are researchers excited about this trial?

Researchers are excited about the Navio™ Robotics-assisted Surgical System because it offers a high-tech twist to traditional knee replacement procedures for osteoarthritis. Unlike conventional surgeries, which rely heavily on the surgeon's skill alone, this system uses advanced robotics to enhance precision, potentially leading to better alignment and improved outcomes. The technology promises to make surgeries less invasive and recovery faster, which is a big deal for patients looking to get back on their feet quickly. This approach represents a significant leap forward in how we tackle knee replacements, aiming to improve both patient experiences and long-term joint function.

What evidence suggests that the Navio™ Robotics-assisted Surgical System is effective for total knee replacement surgery?

Research shows that the Navio™ Robotics-assisted Surgical System, which participants in this trial may receive, provides high accuracy for knee replacements. Studies have found it aligns the knee correctly in over 93% of cases. Proper alignment is crucial for better movement and longer-lasting results. Early evidence suggests that robotic assistance can enhance surgical precision compared to traditional methods. While it has proven effective for partial knee replacements, further research is needed to determine its efficacy for total knee replacements. Participants in this trial will be compared to those receiving a conventional, non-robotics-assisted total knee surgical system.26789

Who Is on the Research Team?

HJ

Herbert John Cooper, MD

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for individuals aged 40-85 with severe knee osteoarthritis who haven't improved after at least 12 weeks of non-surgical treatment. Participants must have a BMI under 40, speak English fluently, and not have had previous open knee surgery or other major knee issues.

Inclusion Criteria

Body mass index (BMI) less than 40.0 kg/m^2
I have tried non-surgical treatments for 12 weeks without improvement.
My knee pain is due to the most severe stage of arthritis.
See 1 more

Exclusion Criteria

I have had swelling or pain in the same knee before due to inflammation.
I have had open knee surgery on the same knee before.
I am willing and able to follow the study's requirements.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either conventional or robotic-assisted total knee arthroplasty

1 day (surgery)
1 visit (in-person)

Post-operative Care

Participants receive standard perioperative care and rehabilitation

6-12 weeks
Multiple visits (in-person)

Follow-up

Participants are monitored for clinical, functional, and radiographic outcomes

Up to 2 years
Regular visits (in-person and virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Navio™ Robotics-assisted Surgical System
Trial Overview The study compares robotic-assisted total knee replacement using the Navio system to conventional surgery. Both groups receive identical care and implants but differ in surgical technique. Patients will undergo x-rays and complete tests to assess their surgery's success.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Navio™ Robotics-assisted Surgical SystemExperimental Treatment1 Intervention
Group II: Non robotics-assisted Surgical SystemActive Control1 Intervention

Navio™ Robotics-assisted Surgical System is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as NAVIO Surgical System for:
🇪🇺
Approved in European Union as NAVIO Surgical System for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Smith & Nephew, Inc.

Industry Sponsor

Trials
176
Recruited
23,500+
Dr. Maria Berkman profile image

Dr. Maria Berkman

Smith & Nephew, Inc.

Chief Medical Officer since 2023

MD from Harvard Medical School

Dr. Deepak Nath profile image

Dr. Deepak Nath

Smith & Nephew, Inc.

Chief Executive Officer since 2022

PhD in Theoretical Mechanics, University of California, Berkeley

Published Research Related to This Trial

In a multicenter clinical trial involving 115 patients, the novel active robotic system for total knee arthroplasty (TKA) demonstrated no pre-defined adverse events, indicating a high level of safety.
The robotic system effectively achieved limb alignment, with only 11.2% of cases showing postoperative alignment more than ±3° from the planned target, suggesting its efficacy in improving surgical outcomes.
Safe and effective use of active robotics for TKA: Early results of a multicenter study.Stulberg, BN., Zadzilka, JD., Kreuzer, S., et al.[2022]
NAVIO robotic-assisted total knee arthroplasty (RATKA) shows comparable short-term outcomes to conventional total knee arthroplasty (CTKA) in terms of early revisions and adverse events, indicating it is a safe surgical option.
While NAVIO RATKA had a longer surgical time (87 minutes vs. 67.6 minutes for CTKA), it also presented a different adverse event profile, with more periprosthetic fractures and persistent wound drainage, suggesting that surgeons should consider these factors when selecting patients for this procedure.
NAVIO RATKA shows similar rates of hemoglobin-drop, adverse events, readmission and early revision vs conventional TKA: a single centre retrospective cohort study.Vandenberk, J., Mievis, J., Deferm, J., et al.[2023]
The 'Skywalker' robot-assisted surgical system demonstrated high precision in total knee arthroplasty (TKA), with cutting jig movements limited to less than 0.25 mm, indicating excellent control during surgery.
The system achieved minimal angle deviations (no more than 1.03°) and resection thickness errors (less than 0.78 mm), suggesting it can significantly enhance the accuracy of osteotomies in knee surgeries.
'Skywalker' surgical robot for total knee arthroplasty: An experimental sawbone study.Xia, R., Tong, Z., Hu, Y., et al.[2021]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/33511584/
Initial Experience with the NAVIO Robotic-Assisted Total ...The RAS system produced accurate coronal alignment in TKA in more than 93% of cases with no learning curve effect. Our study suggests that this system is ...
NCT03317834 | Navio With Total Knee ArthroplastyThe purpose of this study is to demonstrate superior accuracy with the Navio ™ Robotic-assisted Surgical System in achieving desired post-operative ...
NAVIO robotics-assisted total knee replacementArthroscopic surgery is often less effective as osteoarthritis progresses. • Partial knee replacement surgery: a procedure that replaces the single damaged.
Surgical accuracy and clinical outcomes of image‐free ...We aimed to review our early results using the image-free robotic-assisted technology in knee arthroplasty. Methods. A total of 71 patients ...
Navio Robotic Versus Conventional Total Knee ArthroplastyThe present study will evaluate outcomes of robotic-assisted versus conventional total knee replacement surgery in patients between 40 and 85 ...
A Retrospective Study of the Navio Robotic-assisted ...Subjects who had previously received the Navio robotic-assisted surgical system for unilateral knee replacement (UKR) were assessed to determine the 2-year ...
NAVIO◊ Total Knee Replacement SurgeryThe NAVIO◊ Surgical System delivers robotics-assisted tools designed to help tailor total knee replacement surgery to your knee's unique shape and motion.
Complications and downsides of the robotic total knee ...Complications of the robotic system were pin-hole fracture, pin-related infection, iatrogenic soft tissue and bony injury, and excessive blood loss.
Comparison of accuracy and early outcomes in robotic total ...This retrospective study included 88 patients (88 knees) who underwent TKA using the NAVIO (40 patients) or ROSA (48 patients) robotic systems.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security